Product Information

YUSIMRY(CF) 40 MG/0.8 ML PEN is a brand biologic product labeled by Coherus BioSciences Inc, priced at $604.1525 per ML under NDC 70114022002. Its NADAC has been published 56 times since Apr 23, 2025.

YUSIMRY(CF) 40 MG/0.8 ML PEN

adalimumab-aqvh
$604.1525per ML

Strength

40 mg/.8mL

NDC

70114022002

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

5/21/2025

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761216

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price Statistics

The NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has been published 56 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$604.1525 per ML
All-time high$604.1525 (May 13, 2026)
All-time low$604.1525 (Apr 23, 2025)
52-week high$604.1525
52-week low$604.1525
Median price$604.1525
Average price$604.1525
Largest weekly change0.0% (Apr 30, 2025)
Weeks tracked56
Tracking sinceApr 23, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of YUSIMRY(CF) 40 MG/0.8 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for YUSIMRY(CF) 40 MG/0.8 ML PEN, manufactured by Coherus BioSciences Inc, is $604.1525 per ML (NDC 70114022002), effective May 13, 2026.

How has the price of YUSIMRY(CF) 40 MG/0.8 ML PEN changed over time?

Over the history we have for it, the NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for YUSIMRY(CF) 40 MG/0.8 ML PEN?

Since Apr 23, 2025, the NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has ranged from a low of $604.1525 (Apr 23, 2025) to a high of $604.1525 (May 13, 2026), with a median of $604.1525 per ML.

Are there cheaper alternatives to YUSIMRY(CF) 40 MG/0.8 ML PEN?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as YUSIMRY(CF) 40 MG/0.8 ML PEN, but none are currently priced below it.

Who manufactures YUSIMRY(CF) 40 MG/0.8 ML PEN?

YUSIMRY(CF) 40 MG/0.8 ML PEN (NDC 70114022002) is labeled by Coherus BioSciences Inc, and CMS classifies it as a brand biologic product.